AbbVie Inc. | Key People and Executives
Richard A. Gonzalez
Chairman & Chief Executive Officer
Rebecca Brown Roberts
Director
Melody B. Meyer
Independent Director
Brett J. Hart
Independent Director
Frederick H. Waddell
Independent Director
Glenn Fletcher Tilton
Lead Independent Director
Edward J. Rapp
Independent Director
Edward Michael Liddy
Independent Director
William H. L. Burnside
Independent Director
Roxanne Schuh Austin
Independent Director
Robert J. Alpern
Independent Director
Richard A. Gonzalez
Chairman & Chief Executive Officer
Azita Saleki-Gerhardt
Senior Vice President-Operations
William Joseph Chase
Chief Financial Officer & Executive Vice President
Michael E. Severino
Chief Scientific Officer & Executive VP
Scott Brun
Vice President & Head-AbbVie Ventures
Sharon Curran
Vice President-Global Specialty Franchise
Esteban Plata
Vice President-Western Europe & Canada
Henry O. Gosebruch
Chief Strategy Officer & Executive Vice President
Karen Hale
VP, Chief Compliance & Ethics Officer
Carlos Alban
Executive Vice President-Commercial Operations
Rebecca Brown Roberts
Director
Robert A. Michael
Vice President-Controller
Adelle Infante
Director-Corporate Communications
Liz Shea
Head-Investor Relations
Gregory Miley
Vice President-Corporate Communications
Timothy J. Richmond
Senior Vice President-Human Resources
Laura J. Schumacher
Secretary, EVP-External Affairs & General Counsel
Ronald O. Robison
Vice President-Regulatory Affairs
Melody B. Meyer
Independent Director
Brett J. Hart
Independent Director
Frederick H. Waddell
Independent Director
Glenn Fletcher Tilton
Lead Independent Director
Edward J. Rapp
Independent Director
Edward Michael Liddy
Independent Director
William H. L. Burnside
Independent Director
Roxanne Schuh Austin
Independent Director
Robert J. Alpern
Independent Director
| Address |
1 North Waukegan Road
North Chicago Illinois 60064
United States
|
|
Employees
|
- |
| Website |
http://www.abbvie.com |
| Updated |
07/08/2019 |
| AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL. |
